January 04, 2013 at 16:30 PM EST
Gilead Sciences to Present at the 31st Annual JPMorgan Healthcare Conference on Monday, January 7

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 31st Annual JPMorgan Healthcare Conference in San Francisco.

John C. Martin, PhD, Gilead’s Chairman and Chief Executive Officer, will provide an overview of the company on Monday, January 7 at 3:30 p.m. Pacific Time (6:30 p.m. Eastern Time).

To access the live webcast or a replay via the internet, log on to www.gilead.com. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Contacts:

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here